References
- Boring CC, Squires TS, Tong T. Cancer statistics: 1991. CA 1991; 41(1): 19–36 [erratum, CA 1991: 41(2): 111]
- Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of bladder cancer. In: Skinner DG, Lieskovsky G, eds. Diagnosis and management of genitourinary cancer. Philadelphia: WB Saunders, 1988: 23–31
- Rosai J, ed. Ackerman's surgical pathology. 6th ed. St Louis: Mosby-Year Book, 1981: 833
- Althausen AF, Prout GR Jr, Daly JJ. Noninvasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 1976: 116: 575
- Badalament RA, Drago JR. Bladder cancer: what's new in diagnosis and treatment? Postgrad Med 1990: 88(4): 63–70
- US Preventive Services Task Force. Guide to clinical preventive services: an assessment of the effectiveness of 169 interventions. Baltimore: Williams & Wilkins, 1989: 155–62
- Murphy WM, Soloway MS, Jukkola AF, et al. Urinary cytology and bladder cancer: the cellular features of transitional cell neoplasms. Cancer 1984: 53(7): 1555–65
- Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can Med Assoc J 1979: 121: 1–45
- Klein FA, White FK. Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience. J Urol 1988: 139(2): 275–8
- Badalament RA, Kimmel M, Gay H, et al. The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma. Cancer 1987: 59(12): 2078–85
- Boswell WD. Diagnostic imaging in genitourinary cancer. In: Skinner, Lieskovsky, eds,2 pp 237–63
- Jewett HJ, Strong GH. Infiltrating carcinoma of the bladder: relation of depth of penetration of the bladder wall to incidence of local extension and metastasis. J Urol 1946: 55: 366–72
- Shinka T, Uekado Y, Aoshi H, et al. Occurrence of uroepithelial tumors of the upper urinary tract after the initial diagnosis of bladder cancer. J Urol 1988: 140(4): 745–8
- Shipley WU, Kaufman SD, Prout GR Jr. Intraoperative radiation therapy in patients with bladder cancer: a review of techniques allowing improved tumor doses and providing high cure rates without loss of bladder function. Cancer 1987: 60(7): 1485–8
- Greven KM, Solin LJ, Hanks GE. Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer 1990: 65(4): 908–12
- Prout GR Jr, Lin CW, Benson R Jr, et al. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. N Engl J Med 1987: 317(20): 1251–5
- Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 1976: 116(2): 180–3
- Catalona WJ, Dresner SM, Haaff EO. Management of superficial bladder cancer. In: Skinner, Lieskovsky, eds, 2 pp 281–94
- Skinner DG, Tift JP, Kaufinan JJ. High dose, short course preoperative radiation therapy and immediate single stage radical cystectomy with pelvic node dissection in the management of bladder cancer. J Urol 1982: 127(Apr): 671
- Scher H, Herr H, Sternberg C, et al. Neo-adjuvant chemotherapy for invasive bladder cancer: experience with the M-VAC regimen. Br J Urol 1989: 64(3): 250–6
- Logothetis CJ, Dexeus FH, Chong C, et al. Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience. J Urol 1989: 141 (1): 33–7
- Shipley WU, Kaufman SD, Prout GR Jr. The role of radiation therapy and chemotherapy in the treatment of invasive carcinoma of the urinary bladder. Semin Oncol 1988: 15(4): 390–5
- Shipley WU, Prout GR Jr, Einstein AB, et al. Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 1987: 258(7): 931–5